The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

Wed, 29th Sep 2021 09:23

(Adds background)

LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British
supermarket Morrisons will be decided at an auction on
Saturday, when two U.S. private equity groups will go
head-to-head in up to five rounds of bids.

Britain's Takeover Panel said on Wednesday that Clayton,
Dubilier & Rice (CD&R) and Fortress Investment Group had agreed
to settle the matter in a one-day auction.

CD&R, a U.S. private equity firm, started its pursuit of
Britain's fourth-largest grocer in June.

Softbank-backed Fortress entered the fray in July, winning
the backing of the board of Morrisons for bids at 252 pence and
then 270 pence a share.

CD&R returned to trump Fortress with a 285-pence offer,
valuing the supermarket at 7 billion pounds ($9.5 billion).

Given that neither bidder had declared its offer final, the
Takeover Panel said all of the parties had agreed to an auction
process to decide the outcome.

Morrisons shares were trading up 1.3% at 296 pence in early
trading on Wednesday.

The battle for Morrisons is the most high-profile amid a
raft of bids for British companies this year, reflecting private
equity's appetite for cash-generating UK assets.

With more than one bidder increasingly targeting one
company, previously rare auctions have become more frequent.

The most recent on Sept. 22 resulted in a consortium of
funds managed by Ancala Partners and Fiera Infrastructure paying
372 pence a share to buy waste management company Augean, a near
10% rise on the highest offer before the auction.

Other auctions set up this year to decide the fate of
security firm G4S and pharmaceutical company Vectura were
scrapped when one of the parties declared their bid final, a
development that could still scupper the Morrisons tussle.

($1 = 0.7311 pounds)
(Reporting by Paul Sandle; Editing by Kate Holton and
Bernadette Baum)

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.